pcDNA™4/TO Mammalian Expression Vector
Product Image
Invitrogen™

pcDNA™4/TO Mammalian Expression Vector

Sistema de expresión regulado por tetraciclina sin transactivadores viralesEl sistema T-REx™ produce niveles más altos de expresión inducida que cualquierMás información
Have Questions?
Número de catálogoCantidad
V102020
también denominado V1020-20
20μg
Número de catálogo V102020
también denominado V1020-20
Precio (MXN)
-
Cantidad:
20μg
Sistema de expresión regulado por tetraciclina sin transactivadores viralesEl sistema T-REx™
produce niveles más altos de expresión inducida que cualquier otro sistema de expresión de mamíferos regulado. Utiliza el promotor de CMV completo y añade elementos de control al operón de resistencia bacteriana a la tetraciclina para reprimir eficazmente y volver a reprimir la transcripción de una de las secuencias promotoras de mamíferos más fuertes que se conocen (1,2).

Activación específica
El sistema T-REx ™ utiliza un mecanismo represor que bloquea la transcripción del poderoso promotor del CMV en ausencia de tetraciclina. Debido a que los elementos del sistema T-REx™ no utilizan transactivadores virales, puede lograr una expresión de alto nivel a partir de un promotor del CMV completo sin la activación secundaria y no específica de los genes anfitriones.

Mecanismo T-REx™
Los elementos de control transcripcional
T-REx™ se ilustran en la Figura 1. Se han insertado dos secuencias de operador de tetraciclina (TetO2) entre la caja TATA del promotor de CMV y el sitio de inicio transcripcional: La secuencia de TetO2 en sí no tiene efecto en la expresión. Cuando la proteína represora de tetraciclina (TR) está presente, se une eficazmente a los sitios de TetO2 y bloquea el inicio de la transcripción La tetraciclina añadida al medio de cultivo se une a la proteína TR y cambia su conformación. Este cambio hace que la proteína TR libere los sitios de TetO2, lo que reduce la transcripción del promotor del CMV. El resultado es una expresión de alto nivel del gen de interés (Figura 2). Los niveles de expresión se pueden modular en función de la concentración de tetraciclina y pueden inducirse a niveles que se logran con vectores de expresión CMV constitutiva.
T-REx™ es un potente sistema de expresión de mamíferos inducible que permite regular la expresión de un potenciador-promotor del citomegalovirus (CMV). Los vectores de expresión inducible T-REx™ofrecen las siguientes funciones:

• Secuencia completa del potenciador-promotor de CMV que contiene dos copias de la secuencia de operador de tetraciclina TetO2 para una expresión regulada de alto nivel
• Zeocin™ o el gen de resistencia a la higromicina para la selección eficaz de líneas de células de mamíferos estables
• Sitio de clonación múltiple de gran tamaño para simplificar la clonación

Además, pcDNA™4/TO/myc-His ofrece un epítopo c-myc para una detección rápida de proteínas recombinantes con un anticuerpo Anti-myc y una secuencia de polihistidina (6xHis) para una purificación sencilla de la proteína recombinante con resina quelante de níquel y una detección con el anticuerpo Anti- His(C-terminal).

Vector regulador, pcDNA™6/TR, proporcionado para la expresión de alto nivel de la proteína represora de tetraciclina (TR). Este vector expresa el gen de resistencia a la blasticidina para una selección rápida de líneas de células de mamíferos que expresan la proteína TR de forma estable.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Sistema constitutivo o inducibleInducible
Tipo de entregaTransfección
Para utilizar con (aplicación)Expresión regulada
Agente inductorTetraciclina
Tipo de productoVector de expresión de mamíferos
Cantidad20μg
Agente de selección (eucariótico)Zeocin™
VectorpcDNA
Método de clonaciónEnzimas de restricción/MCS
Línea de productosT-REx, pcDNA
PromotorCMV/TO
Etiqueta de proteínaSin etiquetar
Unit Size20 µg

Preguntas frecuentes

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.

Do you offer a GFP-expressing mammalian expression vector that I can use as a control to monitor my transfection and expression?

We offer pJTI R4 Exp CMV EmGFP pA Vector, Cat. No. A14146, which you can use to monitor your transfection and expression.

Citations & References (5)

Citations & References
Abstract
Retention of mutant low density lipoprotein receptor in ER leads to ER stress.
Authors:Sørensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA,
Journal:J Biol Chem
PubMed ID:16257961
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the gene encoding the low density lipoprotein receptor (LDLR). More than 50% of these mutations lead to receptor proteins that are completely or partly retained in the endoplasmic reticulum (ER). The mechanisms involved in the intracellular processing and ... More
BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts.
Authors:Sarig R, Zaltsman Y, Marcellus RC, Flavell R, Mak TW, Gross A,
Journal:J Biol Chem
PubMed ID:12519725
The proapoptotic activity of BID seems to solely depend upon its cleavage to truncated tBID. Here we demonstrate that expression of a caspase-8 non-cleavable (nc) BID-D59A mutant or expression of wild type (wt) BID induces apoptosis in Bid -/-, caspase-8 -/-, and wt primary MEFs. Western blot analysis indicated that ... More
Cell Cycle Regulation and p53 Activation by Protein Phosphatase 2Calpha.
Authors:Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M, Lavi S,
Journal:J Biol Chem
PubMed ID:12514180
Protein phosphatase 2C (PP2C) dephosphorylates a broad range of substrates, regulating stress response and growth-related pathways in both prokaryotes and eukaryotes. We now demonstrate that PP2Calpha, a major mammalian isoform, inhibits cell growth and activates the p53 pathway. In 293 cell clones, in which PP2Calpha expression is regulated by a ... More
The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus.
Authors: Gao Y; Pimplikar S W;
Journal:Proc Natl Acad Sci U S A
PubMed ID:11742091
Sequential processing of the amyloid precursor protein (APP) by beta- and gamma-secretases generates the Abeta peptide, a major constituent of the senile plaques observed in Alzheimer's disease. The cleavage by gamma-secretase also results in the cytoplasmic release of a 59- or 57-residue-long C-terminal fragment (Cgamma). This processing resembles regulated intramembrane ... More
ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.
Authors: Nghiem Paul; Park Peter K; Kim Ys Yong-son; Desai Bimal N; Schreiber Stuart L;
Journal:J Biol Chem
PubMed ID:11711532
ATR (ataxia telangiectasia and Rad-3-related) is a protein kinase required for survival after DNA damage. A critical role for ATR has been hypothesized to be the regulation of p53 and other cell cycle checkpoints. ATR has been shown to phosphorylate p53 at Ser(15), and this damage-induced phosphorylation is diminished by ... More